Evidence map›Paper›PMID 29432922›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2018

Use of Appropriate Surveillance for Patients With Nondysplastic Barrett's Esophagus.

Anna Tavakkoli, Henry D Appelman, David G Beer, Chaitra Madiyal, Maryam Khodadost, Kimberly Nofz, Val Metko, Grace Elta, Thomas Wang, Joel H Rubenstein

Abstract read
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Quality indicators for upper GI endoscopy.Gastrointestinal endoscopy · 2025
    Guideline
  2. Observational
  3. Quality Indicators for Upper GI Endoscopy.The American journal of gastroenterology · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anna TavakkoliBarrett's Esophagus Program, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan. Electronic address: annatav@med.umich.edu.
Henry D AppelmanDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.
David G BeerDepartment of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan.
Chaitra MadiyalBarrett's Esophagus Program, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan.
Maryam KhodadostBarrett's Esophagus Program, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan; Division of Gastroenterology, Veterans Affairs Hospital, Ann Arbor, Michigan.
Kimberly NofzBarrett's Esophagus Program, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan; Division of Gastroenterology, Veterans Affairs Hospital, Ann Arbor, Michigan.
Val MetkoBarrett's Esophagus Program, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan; Division of Gastroenterology, Veterans Affairs Hospital, Ann Arbor, Michigan.
Grace EltaDivision of Gastroenterology, University of Michigan, Ann Arbor, Michigan.
Thomas WangBarrett's Esophagus Program, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan.
Joel H RubensteinBarrett's Esophagus Program, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan; Veterans Affairs Center for Clinical Management Research, Ann Arbor, Michigan.

Funding

Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Validation & Pathology CoreU54CA163059 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUBENSTEIN, JOEL H, WANG, THOMAS D · 2011 to 2022
$12.1M
Controlling Esophageal Cancer: A Collaborative Modeling ApproachU01CA199336 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HUR, CHIN, INADOMI, JOHN MATTHEW · 2015 to 2019
$5.9M
Validation and Extension of the Michigan Barretts Esophagus pREdiction Tool (M-BERET)I01CX000899 · VA · VETERANS HEALTH ADMINISTRATION · PI RUBENSTEIN, JOEL H · 2015 to 2018
–
CSRD VA I01 CX000899NCATS NIH HHS UL1 TR000433NCI NIH HHS U01 CA199336NCI NIH HHS U54 CA163059
6 · The paper itself

Abstract

BACKGROUND &

aimsBarrett's esophagus (BE) is a precursor to esophageal adenocarcinoma (EAC). Guidelines recommend that patients with nondysplastic BE (NDBE) undergo surveillance endoscopy every 3-5 years. We aimed to identify factors associated with surveillance endoscopy of patients with NDBE and identify trends in appropriate surveillance endoscopy of NDBE at a large tertiary care center.

methodsWe performed a retrospective analysis of data from a Barrett's Esophagus Registry, identifying patients with NDBE who underwent endoscopy in 2002 or later. We identified patients with NDBE and collected data on length of BE segment, esophageal lesions, demographic features, medications, histology findings, comorbidities, development of EAC, and dates of follow-up endoscopies. We defined appropriate surveillance as 3-5 years between 2nd and 3rd endoscopies, over-utilizers as patients who had less than 3 years between their 2nd and 3rd endoscopies, under-utilizers as patients who had more than 5 years between their 2nd and 3rd endoscopies; and never-surveilled as patients who never received a 2nd endoscopy. The primary outcomes were effects of patient factors, year, and referring providers on appropriateness of surveillance intervals.

resultsWe identified 477 patients with NDBE. Only 15.9% had appropriate surveillance; 37.9% were over-utilizers 15.7% were under-utilizers and 30.4% were never surveilled. Patients were less likely to be over-surveilled if their primary care physician referred them for their 3rd endoscopy instead of a gastroenterologist (adjusted odds ratio, 0.51; 95% CI, 0.27-0.95). Male patients or those with an increased number of comorbidities were more likely to be under-surveilled or never-surveilled, whereas patients with long BE segment were more likely to be over-surveilled.

conclusionsIn a retrospective analysis of data from a registry of patients with BE, we found that less than 16% receive appropriate surveillance for NDBE. A primary care provider in the same health system as the endoscopy clinic reduced risk of over-surveillance. This could reflect better coordination of care between specialists and primary care providers.

Indexed as

AdenocarcinomaAdultAgedBarrett EsophagusEarly Detection of CancerEndoscopy, GastrointestinalEsophageal NeoplasmsFacilities and Services UtilizationFemaleHumansMaleMiddle AgedRetrospective StudiesTertiary Care CentersCancer RiskEarly DetectionPCPPrevention

Identifiers

PMID29432922
PMCPMC5962402

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.